🇺🇸 FDA
Patent

US 12083122

Laureth-4 containing topical formulations

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 12083122 (Laureth-4 containing topical formulations) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCUTIS BIOTHERAPEUTICS, INC.
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/573, A61K38/13